BMS ECCO 2024 Symposium
This BMS-sponsored promotional symposium, presented at the European Crohn’s and Colitis Organisation (ECCO) Congress 2024, presents a thought-provoking view on the latest developments in therapeutic modalities for ulcerative colitis (UC). For Healthcare Professionals only. This symposium was organised and funded by Bristol Myers Squibb. BMS medicines and/or product information may be discussed. IMM-GB-2400112